Michael Petusky
Stock Analyst at Barrington Research
(2.20)
# 2,763
Out of 5,174 analysts
234
Total ratings
38.03%
Success rate
-3.33%
Average return
Main Sectors:
Stocks Rated by Michael Petusky
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| LFCR Lifecore Biomedical | Upgrades: Outperform | $5.5 | $4.03 | +36.48% | 7 | Mar 17, 2026 | |
| BVS Bioventus | Maintains: Outperform | $13 → $14 | $9.27 | +51.02% | 2 | Mar 6, 2026 | |
| OPK OPKO Health | Maintains: Outperform | $2.25 → $1.5 | $1.14 | +31.58% | 16 | Mar 2, 2026 | |
| XRAY DENTSPLY SIRONA | Maintains: Outperform | $14 → $17 | $11.69 | +45.49% | 28 | Mar 2, 2026 | |
| ANIK Anika Therapeutics | Maintains: Outperform | $16 → $17 | $14.34 | +18.55% | 22 | Feb 27, 2026 | |
| LMAT LeMaitre Vascular | Maintains: Outperform | $95 → $105 | $110.73 | -5.17% | 15 | Feb 26, 2026 | |
| OFIX Orthofix Medical | Maintains: Outperform | $18 → $17 | $11.87 | +43.22% | 6 | Feb 25, 2026 | |
| MMSI Merit Medical Systems | Maintains: Outperform | $106 → $109 | $67.92 | +60.48% | 26 | Feb 25, 2026 | |
| HSIC Henry Schein | Maintains: Outperform | $79 → $97 | $74.45 | +30.29% | 19 | Feb 25, 2026 | |
| USPH U.S. Physical Therapy | Maintains: Outperform | $103 | $74.71 | +37.88% | 27 | Feb 20, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $93 → $94 | $57.60 | +63.19% | 36 | Feb 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $38 → $42 | $28.50 | +47.37% | 19 | Jan 16, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $1 → $1.5 | $0.87 | +71.66% | 11 | Jan 6, 2026 |
Lifecore Biomedical
Mar 17, 2026
Upgrades: Outperform
Price Target: $5.5
Current: $4.03
Upside: +36.48%
Bioventus
Mar 6, 2026
Maintains: Outperform
Price Target: $13 → $14
Current: $9.27
Upside: +51.02%
OPKO Health
Mar 2, 2026
Maintains: Outperform
Price Target: $2.25 → $1.5
Current: $1.14
Upside: +31.58%
DENTSPLY SIRONA
Mar 2, 2026
Maintains: Outperform
Price Target: $14 → $17
Current: $11.69
Upside: +45.49%
Anika Therapeutics
Feb 27, 2026
Maintains: Outperform
Price Target: $16 → $17
Current: $14.34
Upside: +18.55%
LeMaitre Vascular
Feb 26, 2026
Maintains: Outperform
Price Target: $95 → $105
Current: $110.73
Upside: -5.17%
Orthofix Medical
Feb 25, 2026
Maintains: Outperform
Price Target: $18 → $17
Current: $11.87
Upside: +43.22%
Merit Medical Systems
Feb 25, 2026
Maintains: Outperform
Price Target: $106 → $109
Current: $67.92
Upside: +60.48%
Henry Schein
Feb 25, 2026
Maintains: Outperform
Price Target: $79 → $97
Current: $74.45
Upside: +30.29%
U.S. Physical Therapy
Feb 20, 2026
Maintains: Outperform
Price Target: $103
Current: $74.71
Upside: +37.88%
Feb 6, 2026
Maintains: Outperform
Price Target: $93 → $94
Current: $57.60
Upside: +63.19%
Jan 16, 2026
Maintains: Outperform
Price Target: $38 → $42
Current: $28.50
Upside: +47.37%
Jan 6, 2026
Maintains: Outperform
Price Target: $1 → $1.5
Current: $0.87
Upside: +71.66%